Sarah S Mougalian (Sarah E Schellhorn, Sarah Mougalian)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Positive Breast Cancer

Tyrosine Kinase

Palliative Care

Top Venues

Journal of comparative effectiveness research

JCO oncology practice

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kerigo Ndirangu, Rachel Goldgrub, Vanita Tongbram, Rajee Antony, Bagrat Lalayan, Joyce O'Shaughnessy, Sarah S Mougalian
A clinical systematic literature review of treatments among patients with advanced and/or metastatic human epidermal growth factor receptor 2 positive breast cancer. Journal of comparative effectiveness research (2024)
Kerigo Ndirangu, Rachel Goldgrub, Vanita Tongbram, Rajee Antony, Bagrat Lalayan, Joyce O'Shaughnessy, Sarah S Mougalian
A clinical systematic literature review of treatments among patients with advanced and/or metastatic human epidermal growth factor receptor 2 positive breast cancer. Journal of comparative effectiveness research (2024)
Kerigo Ndirangu, Rachel Goldgrub, Vanita Tongbram, Rajee Antony, Bagrat Lalayan, Joyce O'Shaughnessy, Sarah S Mougalian
A clinical systematic literature review of treatments among patients with advanced and/or metastatic human epidermal growth factor receptor 2 positive breast cancer. Journal of comparative effectiveness research (2024)
Steve Power, Kathleen Bickel, Ronald C Chen, Anne C Chiang, Elizabeth Garrett-Mayer, Issam Makhoul, Sarah S Mougalian, Charles L Shapiro, Robert D Siegel, Cardinale B Smith, Gabrielle Betty Rocque, Mary May Priscilla Kozlik, Stéphanie T S Crist, Arif H Kamal
Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort. JCO oncology practice (2023)
Maitri Kalra, Elizabeth Henry, Kelly E McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin A Schonewolf, Meghna S Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew Kyle Labriola, Catherine Handy Marshall, Kathryn E Beckermann, null null, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study. JMIR cancer 8 (2) (2022)
Issam Makhoul, Michael Anders, Robert D Siegel, Anne Chiang, Merry-Jennifer Markham, Ronald C Chen, Sarah S Mougalian, Konstantinos Arnaoutakis, Meredith Elana Giuliani, Annie Im, Mary May Priscilla Kozlik, Stephanie T S Crist, Elizabeth Garrett-Mayer, Arif H Kamal
Hematology/Oncology Fellowship Programs' Participation in the Quality Oncology Practice Initiative. JCO oncology practice 18 (7) (2022)
Sarah S Mougalian, Jonathan K Kish, Jingchuan Zhang, Djibril Liassou, Bruce A Feinberg
Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States. Advances in therapy 38 (5) (2021)
Wendy Sun, Rebecca Reeve, Timothy Ouellette, Martha Stutsky, Rachel De Jesus, Michael J Huffer, Sarah S Mougalian
Novel Tool to Monitor Adherence to Oral Oncolytics: A Pilot Study. JCO clinical cancer informatics 5 (2021)
Ashley C Pariser, Tannaz Sedghi, Pamela R Soulos, Brigid Killelea, Cary P Gross, Sarah S Mougalian
Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States. Breast cancer research and treatment 178 (2) (2019)
Sarah S Mougalian, Ronda Copher, Jonathan K Kish, Lindsay McAllister, Zhixiao Wang, Mary Broscious, David Garofalo, Janna Radtchenko, Bruce A Feinberg
Clinical benefit of treatment with eribulin mesylate for metastatic triple-negative breast cancer: Long-term outcomes of patients treated in the US community oncology setting. Cancer medicine 7 (9) (2018)